Marksans Pharma Ltd Share Price History : Returns Comparison, Growth Analysis

Home

Insights

History

Marksans Pharma Ltd Share Price History

₹ 5.8 Cr

Volume transacted

196.9 K

stocks traded

Last Updated time: 17 Sep 13:42 PM

Marksans Pharma Ltd

BSE

17 Sep, 2024

292.9-0.9 (-0.3%)

Prev Close

293.85

Open Price

294.65

Bid Price (QTY)

292.9 (0)

Offer Price (QTY)

292.5 (0)

Volume

181266

Today's High / Low

294.6 / 285.0

52 WK High / Low

296.8 / 93.8

NSE

17 Sep, 2024

292.4-1.3 (-0.4%)

Prev Close

293.71

Open Price

294.3

Bid Price (QTY)

292.5 (80)

Offer Price (QTY)

292.4 (54)

Volume

4738287

Today's High / Low

294.3 / 285.0

52 WK High / Low

296.7 / 97.4

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

To make informed investment decisions, regularly checking Marksans Pharma Ltd share price can be a beneficial practice. *All values are in Rupees.

Last Ten Days Share Price

Date	Price	Day Open	Day High	Day Low

16 Sep 2024	293.85	281.95	296.8	280
13 Sep 2024	277.35	270.25	284.3	268.5
12 Sep 2024	268.1	274.25	274.95	266.85
11 Sep 2024	272.85	265.3	276	261.1
10 Sep 2024	263.5	262.7	273.15	259.3
09 Sep 2024	258.5	266.45	266.45	255.5
06 Sep 2024	263	267.95	278.4	261.8
05 Sep 2024	259.3	262.55	263	252.75
04 Sep 2024	261.3	238.7	263.9	238.55
03 Sep 2024	242.7	241.95	247.8	238.9

Date	Price
16 Sep 2024	293.85
13 Sep 2024	277.35
12 Sep 2024	268.1
11 Sep 2024	272.85
10 Sep 2024	263.5
09 Sep 2024	258.5
06 Sep 2024	263
05 Sep 2024	259.3
04 Sep 2024	261.3
03 Sep 2024	242.7

Returns Comparison

10Y

Returns Comparison Table

Entity	1W	1M	3M	6M	1Y	3Y	5Y	10Y

Cipla Ltd	2.4	5.3	5.4	11.6	33.8	74.0	252.8	167.8
Marksans Pharma Ltd	13.7	40.7	83.9	106.4	189.4	313.6	1783.7	387.3
Torrent Pharmaceuticals Ltd	0.8	3.2	19.6	34.5	83.2	121.9	303.9	679.1
Sun Pharmaceuticals Industries Ltd	2.3	6.9	22.5	18.5	62.3	138.6	336.6	133.5
Zydus Lifesciences Ltd	1.0	-6.0	3.4	12.6	73.4	97.7	361.0	338.4
Divis Laboratories Ltd	5.9	18.2	20.1	56.3	44.8	6.1	233.1	555.1

Entity	1W
Cipla Ltd	2.4
Marksans Pharma Ltd	13.7
Torrent Pharmaceuticals Ltd	0.8
Sun Pharmaceuticals Industries Ltd	2.3
Zydus Lifesciences Ltd	1.0
Divis Laboratories Ltd	5.9

Last updated time: 17 Sep 13:42 PM

Growth Parameters

Parameter	2017	2018	2019	2020	2021	2022	2023	2024

Sales	767	913	1000	1134	1376	1491	1852	2177
Sales YoY Gr.	-	19.0%	9.6%	13.4%	21.3%	8.3%	24.2%	17.6%
Adj EPS	0	0.87	1.97	2.95	5.83	4.56	5.85	6.95
YoY Gr.	-	87.0%	126.4%	49.8%	97.6%	-21.8%	28.3%	18.8%
Adj Net Profit	11	36	80	121	239	187	265	315
BVPS	10.59	11.5	13.25	15.54	21.66	27.1	38.51	45.57

Parameter	2017
Sales	767
Sales YoY Gr.	-
Adj EPS	0
YoY Gr.	-
Adj Net Profit	11
BVPS	10.59

Key Financial Parameters

Parameter	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

Return on Capital Emp. %	29.22	18.64	3.36	9.08	17.23	25.02	38.77	22.83	21.77	20.78
Op. Profit Mgn %	23.61	16.25	6.75	9.52	13.68	16.98	25.16	20.17	21.52	23.38
Net Profit Mgn %	14.05	9.26	1.48	3.92	8.04	10.65	17.33	12.53	14.33	14.46
Debt to Equity %	0.48	0.21	0.22	0.25	0.22	0.11	0.04	0.07	0.08	0.1

Parameter	2015
Return on Capital Emp. %	29.22
Op. Profit Mgn %	23.61
Net Profit Mgn %	14.05
Debt to Equity %	0.48

Latest Shareholding

No data available

Promoters Holdings Over Time

No data available

About Marksans Pharma Ltd

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982.
Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October, 2005.
The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai.
In 2004-05, the Company amalgamated with M/s. Marksans Pharma Limited (formerly M/s. Glenmark Laboratories Limited) pursuant to High Court order dated 19th August, 2005.

Check out other companies share price history

Sun Pharmaceuticals Industries Ltd

Sun Pharmaceutical Industries Limited including its subsidiaries and associates ...

Divis Laboratories Ltd

Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the w...

Cipla Ltd

The Company is in the business of manufacturing, developing, and marketing wide ...

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is o...

Zydus Lifesciences Ltd

The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadoda...

Popular Search

Marksans Pharma Ltd dividend

Marksans Pharma Ltd pe ratio

Marksans Pharma Ltd market cap

Marksans Pharma Ltd financials

Sun Pharmaceuticals Industries Ltd share price history

Divis Laboratories Ltd share price history

Cipla Ltd share price history

Torrent Pharmaceuticals Ltd share price history

Zydus Lifesciences Ltd share price history

Dr Reddys Laboratories Ltd share price history

Lupin Ltd share price history

Mankind Pharma Ltd share price history

Aurobindo Pharma Ltd share price history

Alkem Laboratories Ltd share price history

FAQs for of Marksans Pharma Ltd

What factors influence the share price of Marksans Pharma Ltd over time?

The share price of Marksans Pharma Ltd is influenced by factors such as the company's financial performance, including earnings and revenue, as well as broader economic conditions and market trends. Furthermore, developments in the industry, regulatory changes, and geopolitical events can also impact the share price over time.

What are the key events that typically impact Marksans Pharma Ltd's share price history?

Key events that impact Marksans Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.

How do stock splits affect Marksans Pharma Ltd's share price history?

Stock splits reduce the nominal price of Marksans Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.

How do dividends impact the share price history of Marksans Pharma Ltd?

Dividends can influence Marksans Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.

How do corporate announcements affect Marksans Pharma Ltd’s share price history?

Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Marksans Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.

How can I use technical analysis to understand Marksans Pharma Ltd’s share price history?

To understand Marksans Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*